Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Association of Interleukin 13 Polymorphism (rs20541) and Serum Lipocalin 2 with Risk and Disability in Multiple Sclerosis. | J Inflamm Res | 2026 | 41809761 | PubTator, text mining | PubMed |
| Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system. | Ann Hematol | 2026 | 41807658 | PubTator, text mining | PubMed |
| Case Report: Surgical resection combined with chemotherapy for a primary cardiac lymphoma involving right heart structures. | Front Oncol | 2026 | 41800056 | PubTator, text mining | PubMed |
| Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma. | Front Oncol | 2026 | 41800035 | PubTator, text mining | PubMed |
| From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy. | Immune Netw | 2026 | 41800026 | PubTator, text mining | PubMed |
| Dysfunctional decidual CD2+CD4+T cells regulated by Rev-erbα - GFPT1 - GPI anchored CD58 axis of decidual stromal cells underlies sleep disturbance induced recurrent pregnancy loss. | Front Immunol | 2026 | 41789068 | PubTator, text mining | PubMed |
| Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy. | Front Oncol | 2026 | 41788999 | PubTator, text mining | PubMed |
| Modulating immune response for the prevention and treatment of type 1 diabetes. | Front Immunol | 2026 | 41777899 | PubTator, text mining | PubMed |
| Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer. | Cancer Genomics Proteomics | 2026 | 41771575 | PubTator, text mining | PubMed |
| Spontaneous remission of congenital acute megakaryoblastic leukemia in a neonate with down syndrome. | Open Med (Wars) | 2026 | 41767736 | PubTator, text mining | PubMed |
| CD2 costimulation breaks the CD28 vs. 4-1BB tradeoff in CAR T cells. | Mol Ther Oncol | 2026 | 41766925 | PubTator, text mining | PubMed |
| Immuno-Instructive 3D Tendon Biomimetic Scaffolds Functionalized with Amniotic Epithelial Stem Cell Secretome for Controlled Inflammation and Targeted Macrophage Polarization. | Int J Mol Sci | 2026 | 41752165 | PubTator, text mining | PubMed |
| FlowCLOc, a New Tool for Selecting the Most Appropriate Antibodies in Flow Cytometry. | Int J Mol Sci | 2026 | 41751801 | PubTator, text mining | PubMed |
| Cutaneous Dendritic Cells: Structure, Function and Immune Role. | Biomedicines | 2026 | 41751359 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Targeted Treatment of Richter Transformation. | Biomedicines | 2026 | 41751246 | PubTator, text mining | PubMed |
| Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. | Blood Cancer J | 2026 | 41741411 | PubTator, text mining | PubMed |
| Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T. | J Immunother Cancer | 2026 | 41720609 | PubTator, text mining | PubMed |
| Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer. | Front Immunol | 2026 | 41710887 | PubTator, text mining | PubMed |
| Measurable Residual Disease Assessment in B-Lymphoblastic Leukemia Using 5- and 10-Color Flow Cytometry: An Institutional Experience. | Cureus | 2026 | 41704997 | PubTator, text mining | PubMed |
| Oncolytic viruses: advanced strategies in cancer therapy. | Signal Transduct Target Ther | 2026 | 41639062 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=2